Eidos Therapeutics’ $2.83 Billion Merger with BridgeBio Pharma
October 05, 2020
On October 5, 2020, Eidos Therapeutics, Inc. (“Eidos”), a company focused on transthyretin amyloidosis, and BridgeBio Pharma, Inc., a company focused on genetic diseases, announced that they have entered into a definitive agreement under which BridgeBio has agreed to acquire all of the outstanding common stock of Eidos it does not already own, representing approximately 36.3% of Eidos’s outstanding shares, valuing Eidos at approximately $2.83 billion. Eidos stockholders will have the right to receive in the transaction, at their election, either 1.85 shares of BridgeBio common stock or $73.26 in cash per Eidos share in the transaction, up to an aggregate maximum of $175 million of cash. Cravath is representing the Special Committee of the Board of Eidos in connection with the transaction.
The Cravath team is led by partners Mark I. Greene and Aaron M. Gruber and includes associates Andrew M. Wark, Rebecca D. Stacker and Parth S. Baxi on M&A matters; partner Eric W. Hilfers, practice area attorney Sarah W. Colangelo and associates Christopher C. Gonnella and Dixing Tang on executive compensation and benefits matters; partner Lauren Angelilli and associate Arvind Ravichandran on tax matters; partner David J. Kappos and associates Carys Webb and Rohan E. George on intellectual property matters; partner Matthew Morreale on environmental matters; and senior attorney Joyce Law and practice area attorney Laurel R. Berkowitz on real estate matters. Duncan H. Hardell also worked on tax matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 1993, University of Pennsylvania Law School
-
B.A., 1989, Cornell University
- New York
Education
Admitted In
- Photo
-
-
J.D., 2007, Stanford Law SchoolOrder of the Coif
-
M.Phil., 2004, University of CambridgeGates Cambridge Scholar
-
B.S., 2003, Yale Collegesumma cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2013, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.S., 2010, Duke University
- New York
Education
Admitted In
- Photo
-
-
J.D., 1998, University of Chicago Law Schoolwith Honors
-
A.B., 1995, Princeton University
- New York
Education
Admitted In
-
J.D., 2000, Harvard Law Schoolcum laude
-
B.S., 1996, The Wharton School of the University of Pennsylvaniamagna cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2012, Columbia Law School
-
B.A., 2009, Columbia College
- New York
Education
Admitted In
- Photo
-
-
J.D., 1990, University of California, Berkeley, School of Law
-
B.S., 1983, University of California, Davissumma cum laude
- New York
- California
- District of Columbia
Education
Admitted In
- Photo
-
-
J.D., 1997, Columbia Law SchoolHarlan Fiske Stone Scholar
-
M.S., 1994, University of Pennsylvania
-
B.A., 1990, University of Pennsylvania
-
B.A.S., 1990, University of Pennsylvania
- New York
Education
Admitted In
- Photo
-
-
J.D., 2014, Georgetown University Law CenterOrder of the Coif, magna cum laude
-
B.A., 2007, Duke UniversityPhi Beta Kappa, summa cum laude
- New York
Education
Admitted In
-
J.D., 1997, Boston University School of Law
-
B.Comm., 1994, University of AlbertaDistinction
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
September 25, 2020
Amentum’s Acquisition of DynCorp International
On September 24, 2020, Amentum Holdings LLC (“Amentum”), a leading contractor to U.S. federal and allied governments jointly owned by Lindsay Goldberg and American Securities, and DynCorp International (“DynCorp”), a worldwide leader in aviation and logistics support services, announced a definitive agreement under which an affiliate of Amentum will acquire DynCorp. The acquisition, once finalized, will create one of the largest providers of mission‑critical support services, with more than $6 billion of combined revenue over the last 12 months. Cravath is representing Amentum, Lindsay Goldberg and American Securities in connection with the transaction.
Deals & Cases
September 25, 2020
binderholz Group’s Acquisition of Substantially all the Assets of Klausner Lumber One through a 363 Sale
On August 22, 2020, the Austria-based binderholz Group, a leading European company for solid wood products and innovative building solutions, announced it had entered into a definitive agreement to purchase substantially all the assets of the Florida‑based sawmill operator Klausner Lumber One, LLC after prevailing in an auction held on August 21, 2020 pursuant to Section 363 of the United States Bankruptcy Code. Klausner Lumber One, LLC is currently in Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware. Cravath is representing binderholz Group in connection with the transaction, which closed on September 21, 2020.
Deals & Cases
September 21, 2020
Illumina’s $8 Billion Acquisition of GRAIL
On September 21, 2020, Illumina, Inc. (“Illumina”) and GRAIL announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion. In addition, GRAIL shareholders will receive future payments representing a tiered single digit percentage of certain GRAIL-related revenues. GRAIL, a healthcare company focused on multi-cancer early detection, was founded by Illumina, a global leader in DNA sequencing and array-based technologies, in 2016 and spun out as a standalone company. Cravath is representing Illumina in connection with the transaction.
Deals & Cases
September 14, 2020
Scientific Games’ Sale of a 34.9% Stake to Institutional Investors, including Caledonia
On September 14, 2020, Scientific Games Corporation (“Scientific Games”) announced that a number of long‑term institutional investors, including gaming industry investor Caledonia, have reached agreement to acquire a 34.9% stake in Scientific Games from MacAndrews & Forbes Incorporated at a price of $28.00 per share. In connection with the transaction, Scientific Games is implementing a series of governance changes and enhancements to reflect its new investor base and continue to position the Company for growth and value creation. Cravath is representing Scientific Games and its Special Committee of the Board of Directors in connection with the transaction.
